(SRPT) Sarepta Therapeutics - Performance -50.8% in 12m
Compare SRPT with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-30.39%
#55 in Group
Rel. Strength
11.56%
#6757 in Universe
Total Return 12m
-50.81%
#98 in Group
Total Return 5y
-38.19%
#58 in Group
P/E 26.5
65th Percentile in Group
P/E Forward 7.49
35th Percentile in Group
PEG 159
100th Percentile in Group
FCF Yield -5.83%
62th Percentile in Group
12m Total Return: SRPT (-50.8%) vs XBI (-11%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
ABBV NYSE AbbVie |
-2.97% | 17.7% | 234% | 84.1 | 16.4 | 0.42 | -49.6% | -19% |
UTHR NASDAQ United Therapeutics |
0.72% | 36.6% | 226% | 13 | 11.3 | 1.43 | 83.8% | 78.5% |
HLN NYSE Haleon |
-3.97% | 23.4% | 39.7% | 25.6 | 20.9 | 1.85 | -38.6% | -24.4% |
AMGN NASDAQ Amgen |
-1.63% | 14.1% | 68.5% | 40.5 | 14.8 | 1.04 | -18.8% | -20% |
LONN SW Lonza |
-7.89% | 0.58% | 37% | 60.5 | 31.8 | 1.16 | 12.6% | -10.3% |
NBIX NASDAQ Neurocrine Biosciences |
-5.39% | -21.4% | 18.7% | 33.6 | 22.8 | 0.27 | 61.5% | 31.6% |
BIM PA Biomerieux |
1.3% | 15.8% | 12.1% | 31.4 | 25.8 | 1.47 | -47.6% | -26.9% |
KMDA NASDAQ Kamada |
1.65% | 24.1% | 14.1% | 27 | 25 | 1 | 58.7% | 15% |
Performance Comparison: SRPT vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for SRPT
Total Return (including Dividends) | SRPT | XBI | S&P 500 |
---|---|---|---|
1 Month | -38.28% | -5.85% | -3.01% |
3 Months | -49.66% | -11.95% | -3.15% |
12 Months | -50.81% | -11.00% | 10.19% |
5 Years | -38.19% | 0.65% | 129.24% |
Trend Score (consistency of price movement) | SRPT | XBI | S&P 500 |
1 Month | -94.9% | -59.8% | -5.5% |
3 Months | -98.0% | -70.5% | -58.4% |
12 Months | -62.3% | -6.9% | 84.1% |
5 Years | 10.1% | -50% | 84.4% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #189 | -34.5% | -36.4% |
3 Month | #171 | -42.8% | -48.0% |
12 Month | #99 | -44.7% | -55.4% |
5 Years | #60 | -38.6% | -73.0% |
FAQs
Does SRPT Sarepta Therapeutics outperforms the market?
No,
over the last 12 months SRPT made -50.81%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.00%.
Over the last 3 months SRPT made -49.66%, while XBI made -11.95%.
Over the last 3 months SRPT made -49.66%, while XBI made -11.95%.
Performance Comparison SRPT vs Indeces and Sectors
SRPT vs. Indices SRPT is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -13.6% | -35.3% | -48.9% | -61.0% |
US NASDAQ 100 | QQQ | -12.6% | -34.2% | -48.1% | -59.4% |
US Dow Jones Industrial 30 | DIA | -13.8% | -36.1% | -49.8% | -60.3% |
German DAX 40 | DAX | -12.3% | -34.9% | -65.7% | -72.5% |
Shanghai Shenzhen CSI 300 | CSI 300 | -13.3% | -38.5% | -33.7% | -59.9% |
Hongkong Hang Seng | HSI | -15.5% | -41.1% | -39.7% | -68.1% |
India NIFTY 50 | INDA | -14.6% | -46.2% | -38.5% | -51.5% |
Brasil Bovespa | EWZ | -13.7% | -46.6% | -40.9% | -39.1% |
SRPT vs. Sectors SRPT is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -12.0% | -34.5% | -57.0% | -70.0% |
Consumer Discretionary | XLY | -14.3% | -34.5% | -52.2% | -64.9% |
Consumer Staples | XLP | -16.4% | -36.4% | -49.7% | -61.8% |
Energy | XLE | -14.7% | -46.3% | -54.5% | -51.6% |
Financial | XLF | -14.0% | -35.6% | -61.0% | -73.1% |
Health Care | XLV | -14.0% | -35.1% | -44.2% | -52.5% |
Industrial | XLI | -13.9% | -37.6% | -48.2% | -59.3% |
Materials | XLB | -14.7% | -38.8% | -40.8% | -46.9% |
Real Estate | XLRE | -15.6% | -35.6% | -45.8% | -64.2% |
Technology | XLK | -12.4% | -34.3% | -43.8% | -52.8% |
Utilities | XLU | -16.9% | -39.1% | -48.0% | -76.0% |
Aerospace & Defense | XAR | -13.0% | -39.6% | -52.8% | -71.7% |
Biotech | XBI | -9.0% | -32.4% | -31.2% | -39.8% |
Homebuilder | XHB | -14.1% | -38.4% | -29.5% | -43.1% |
Retail | XRT | -15.9% | -37.8% | -44.8% | -46.0% |